A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
Public ClinicalTrials.gov record NCT03771664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult participants with comorbid major depressive disorder (MDD) and insomnia.
Study identification
- NCT ID
- NCT03771664
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2019
- Primary completion
- Dec 19, 2019
- Completion
- Jan 16, 2020
- Last update posted
- Nov 28, 2023
2019 – 2020
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sage Investigational Site | Little Rock | Arkansas | 72211 | — |
| Sage Investigational Site | Rogers | Arkansas | 72758 | — |
| Sage Investigational Site | Garden Grove | California | 92845 | — |
| Sage Investigational Site | Oceanside | California | 92056 | — |
| Sage Investigational Site | San Diego | California | 92103 | — |
| Sage Investigational Site | Temecula | California | 92591 | — |
| Sage Investigational Site | Fort Myers | Florida | 33912 | — |
| Sage Investigational Site | Hollywood | Florida | 33024 | — |
| Sage Investigational Site | Miami Lakes | Florida | 33016 | — |
| Sage Investigational Site | North Miami | Florida | 33161 | — |
| Sage Investigational Site | Atlanta | Georgia | 30331 | — |
| Sage Investigational Site | Atlanta | Georgia | 30342 | — |
| Sage Investigational Site | Decatur | Georgia | 30030 | — |
| Sage Investigational Site | Chicago | Illinois | 60634 | — |
| Sage Investigational Site | Lake Charles | Louisiana | 70629 | — |
| Sage Investigational Site | Flowood | Mississippi | 39232 | — |
| Sage Investigational Site | St Louis | Missouri | 63141 | — |
| Sage Investigational Site | Las Vegas | Nevada | 89102 | — |
| Sage Investigational Site | Berlin | New Jersey | 08009 | — |
| Sage Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Sage Investigational Site | Brooklyn | New York | 11235 | — |
| Sage Investigational Site | New York | New York | 10019 | — |
| Sage Investigational Site | Cincinnati | Ohio | 45212 | — |
| Sage Investigational Site | Dayton | Ohio | 45417 | — |
| Sage Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Sage Investigational Site | Salem | Oregon | 97301 | — |
| Sage Investigational Site | Charleston | South Carolina | 29407 | — |
| Sage Investigational Site | Austin | Texas | 78754 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03771664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 28, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03771664 live on ClinicalTrials.gov.